J. Barbera (Barcelona, Spain), R. Schermuly (Giessen, Germany)
Pulmonary hypertension associated with chronic obstructive pulmonary disease
G. Karabiyikoglu, Z. P. Onen, O. Akooca Yildiz (Ankara, Turkey)
|  |
Pulmonary artery hypertension and severity of airflow limitation in COPD patients
H. Jamaati, P. Pajouh, M. Malekmohammad, M. Nayebi, K. Jafari (Tehran, Islamic Republic Of Iran)
| |
Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results)
S. Marinari, S. Gallina, M. L. Storto, A. D‘Intino, F. De Benedetto (Chieti, Italy)
| |
Pulmonary hypertension in chronic obstructive pulmonary disease: the role of cigarette smoking
A. Gaballo, G. M. Corbo, C. Colizzi, L. Paladini, G. Pasciuto, V. Rizzello, F. Pennestri, G. Ciappi, S. Valente (Rome, Italy)
| |
Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome
J. Jareño-Esteban, J. I. de Granda-Orive, V. Gallego-Rodríguez, T. Gutierrez-Jimenez, S. Alvarez, F. Roig-Vazquez, F. Villegas-Fernandez, E. Arias-Arias, A. Rodero-Baños, J. M. MNartinez Albiach (Madrid, Spain)
| |
Dependence of mean pulmonary artery pressure from cytokine inflammation activity and remodeling index of pulmonary circulation
O. A. Tsvetkova, M. V. Veselovskaya (Moscow, Russian Federation)
| |
The effect of estrogen and its receptor on hypoxic pulmonary vascular remodeling
S. Sun, Y. Lin (Nanjing, China)
| |
Hypoxic pulmonary vasoconstriction – the role of cytochromes in oxygen sensing investigated by remission spectrophotometry in isolated lungs
N. Sommer, H. A. Ghofrani, R. T. Schermuly, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Germany)
| |
Histopathologic changes, cellular apoptosis, and pulmonary vasculitis, with related immunogenetic changes in schistosomal corpulmonale patients
W. El-Hosseiny (Alexandria, Egypt)
| |
Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH
D. Langleben, S. Orfanos, M. Giovinazzo, A. Hirsch, J. D. Catravas (Montreal, Canada; Athens, Greece; Augusta, United States Of America)
| |
Prognoctic value of platelet factor-4 and thrombin-antithrombin complex for pulmonary hypertension among patients with idiopathic interstitial pneumonias
E. N. Popova, E. A. Kogan, A. B. Ponomarev, I. A. Popova, V. I. Osipenko (Moscow, Russian Federation)
| |
Alterations in the expression of proteoglycans and glycosaminoglycans in pulmonary hypertension
E. Papakonstantinou, F. Kouri, I. Klangas, G. Karakiulakis, O. Eickelberg (Thessaloniki, Greece; Giessen, Germany)
| |
Clinical and prognostic value of atrial natriutic peptide in patients with idiopathic pulmonary hypertension
T. V. Martynyk, O. O. Matvienko, N. M. Danilov, V. P. Masenko, I. E. Chazova (Moscow, Russian Federation)
| |
Acute lung injury induced by the pyrrolizidine alkaloid monocrotaline in mice
R. T. Schermuly, R. Dumitrascu, S. Köbrich, H. Traupe, E. Dony, S. Pullamsetti, R. Savai, N. Weissmann, H. A. Ghofrani, W. Seeger, F. Grimminger (Giessen, Germany)
| |
Expression vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets
A. Vuckovic, B. Rondelet, R. Van Beneden, M. Remmelink, J. P. Brion, R. Naeije (Brussels, Belgium)
| |
Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension
S. Ulrich, M. Nicolls, R. Speich, L. Taraseviciene, N. Voelkel (Zurich, Switzerland; Denver, United States Of America)
| |
Efficacy of a 12 months oral sildenafil treatment in patients with severe pulmonary hypertension
M. Samarzija, M. Jakopovic, G. Redzepi, E. Zuljevic, B. Sever, S. Plestina, N. Miculinic, F. Pavicic (Zagreb, Croatia)
| |